22 April 2013

DSM announces June opening of new cGMP biopharmaceutical manufacturing operation in Brisbane, Australia

Consolidation of the Asia-Pacific region through strategic development in the biopharmaceutical industry

DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM, announced today that their new cGMP custom biopharmaceutical manufacturing ‘biologics plant of the future’ will open in June 2013.

The DSM facility was built with cooperation from the Queensland and Commonwealth Governments of Australia. Karen King, President of DSM Biologics, the biopharmaceutical manufacturing business of DSM Pharmaceutical Products, stated, …

… Full text: www.prnewswire.com/news-releases-test/dsm-announces-june-opening-of-new-cgmp-biopharmaceutical-manufacturing-operation-in-brisbane-australia-204037621.html

Tags: growth area, local alliances, biopharmaceutical manufacturing, bioprocessing technology

Source: PR Newswire, press release, 2013-04-22.


Share on Twitter+1Share on FacebookShare on XingShare on LinkedInShare via email